Deo S V S, Manjunath N M L, Shukla N K
Department of Surgical Oncology, Institute Rotary cancer Hospital, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029 India.
Indian J Surg. 2012 Jun;74(3):228-33. doi: 10.1007/s12262-012-0587-4. Epub 2012 Jun 20.
Soft tissue sarcomas (STS) constitute a rare and challenging group of solid tumor in the field of oncology. Unlike other malignancies STS can affect a wide variety of anatomical regions in the body with varied histo-pathological variants and clinical outcomes. There are controversies in the diagnosis and management of STS due to rarity and heterogeneity of the disease entity. Due to dedicated research and advances made in the field of imaging, pathology, surgery, radiotherapy and chemotherapy certain controversies were laid to rest and treatment approach to STS could be standardized to a large extent in the recent past. A review of controversies related to STS was performed in this article and an attempt was made to present a balanced view pertaining to these issues.
软组织肉瘤（STS）是肿瘤学领域中一类罕见且具有挑战性的实体肿瘤。与其他恶性肿瘤不同，STS可累及身体的多种解剖区域，具有多样的组织病理学变异和临床结局。由于该疾病实体的罕见性和异质性，在STS的诊断和治疗方面存在争议。得益于在影像学、病理学、手术、放疗和化疗领域的专门研究及进展，某些争议已得到解决，并且在最近一段时间，STS的治疗方法在很大程度上得以标准化。本文对与STS相关的争议进行了综述，并试图就这些问题呈现一种平衡的观点。
